Hussam Al-Kateb, MSc, PhD, FACMGG

Associate Professor, Pathology - (Clinical Scholar Track)
Medical Director, University of Arizona Genetic Core for Clinical Services (UAGC-CS) Laboratory
Director, Cytogenomic Laboratory, Banner University Medical Center

Dr. Al-Kateb comes from the Washington University School of Medicine in St. Louis, where he served as Assistant Professor in the Department of Pathology and Immunology for five years. Dr. Al-Kateb’s international training includes a Bachelor’s degree in Pharmacy and Pharmaceutical Chemistry, and a Master’s degree in Clinical Pathology, both from the School of Pharmacy, Damascus University; a Doctorate degree  (summa cum laude) in Human Molecular Genetics from the University of Heidelberg, Germany; post-doctoral fellowship training at the Hospital for Sick Children in Canada; and  fellowship training in both Clinical Cytogenetics and Clinical Molecular Genetics at Case Western Reserve University, Ohio. He is dually boarded by the American Board of Medical Genetics and Genomics (ABMGG) in Clinical Cytogenetics and Clinical Molecular Genetics and Genomics.

Research Interests: 

As Medical Director of the University of Arizona Genetic Core for Clinical Services Laboratory, Dr. Al-Kateb's focus is on developing clinical genetic tests that aim at identifying somatic mutations to be used for cancer targeted therapy, and developing clinical genetic tests that seek to identify germline mutations which underline constitutional genetic disorders using state-of-the art technologies.

Dr. Al-Kateb's has authored more than 56 publications including original articles, abstracts and book chapters. His research interest is in identifying disease genes for both mendelian and complex diseases, genotype-phenotype correlations, identifying genetic markers for cancer and applying NGS technology in the clinic.

  • American College of Medical Genetics and Genomics, 2012
Board Certifications
  • American Society of Human Genetics - 2004
  • International Genetics Epidemiology Society (IGES), 2005-2006
  • American Diabetes Association, 2006-2007
  • Diplomat of the American Board of Medical Genetics and Genomics - 2011
  • College of American Pathologists, Cytogenetics and Molecular Genetics, 2013

Select Publications


Ma, C. X., F. Gao, J. Luo, D. W. Northfelt, M. Goetz, A. Forero, J. Hoog, M. Naughton, F. Ademuyiwa, R. Suresh, et al., "NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.", Clin Cancer Res, 2017 Mar 07. PMID: 28270497


Al-Kateb, H., TD. T. Nguyen, K. Steger-May, and J. D. Pfeifer, "Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS).", Mol Oncol, vol. 9, issue 9, pp. 1737-43, 2015 Nov. PMID: 26071350
Shinawi, M., R. Coorg, J. S. Shimony, D. K. Grange, and H. Al-Kateb, "Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes.", Clin Genet, vol. 87, issue 5, pp. 478-82, 2015 May. PMID: 24738973
Hagemann, I. S., S. Devarakonda, C. M. Lockwood, D. H. Spencer, K. Guebert, A. J. Bredemeyer, H. Al-Kateb, TD. T. Nguyen, E. J. Duncavage, C. E. Cottrell, et al., "Clinical next-generation sequencing in patients with non-small cell lung cancer.", Cancer, vol. 121, issue 4, pp. 631-9, 2015 Feb 15. PMID: 25345567